Company Filing History:
Years Active: 2016-2021
Title: Innovations by Michael Edward Christe
Introduction
Michael Edward Christe is a notable inventor based in Pendleton, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of rapid-acting insulin compositions. With a total of 4 patents to his name, Christe's work has the potential to improve the lives of many individuals with diabetes.
Latest Patents
Christe's latest patents focus on innovative pharmaceutical compositions of human insulin or insulin analogs. One of his key inventions is a rapid-acting insulin composition that includes citrate, treprostinil, and stabilizing agents. This formulation demonstrates faster pharmacokinetic and/or pharmacodynamic action compared to existing commercial insulin analog products, while also being stable for commercial use. Another significant patent involves a composition of human insulin or insulin analog that incorporates treprostinil, which also exhibits faster pharmacokinetic action than current commercial formulations.
Career Highlights
Michael Edward Christe is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its advancements in diabetes care. His work at Eli Lilly has allowed him to focus on developing innovative solutions that address the needs of patients requiring insulin therapy.
Collaborations
Throughout his career, Christe has collaborated with esteemed colleagues, including Thomas Andrew Hardy and Michael Patrick Akers. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical innovation.
Conclusion
Michael Edward Christe's contributions to the development of rapid-acting insulin compositions highlight his commitment to improving diabetes treatment. His innovative work at Eli Lilly and Company, along with his collaborations, positions him as a key figure in the pharmaceutical industry.